Mersana Therapeutics Stock Income Statements

Mersana Therapeutics Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Mersana Therapeutics Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31
revenue	10,701,000	7,698,000	10,654,000	7,802,000	14,688,000	5,573,000	4,284,000	2,036,000	11,000	11,000	11,000	11,000	11,000	11,000	796,000	11,000	42,000	844,000	202,000	41,035,000	1,188,000	2,151,000	4,191,000	3,064,000	3,261,000	6,267,000	3,727,000	4,290,000	11,996,000	3,262,000	6,215,000	3,697,000
cost of revenue	447,000	427,000	324,000	319,000	282,000	213,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19,817,000	0	0	0	0	0	0	0	0	0	0	0
gross profit	10,254,000	7,271,000	10,330,000	7,483,000	14,406,000	5,360,000	4,284,000	2,036,000	11,000	11,000	11,000	11,000	11,000	11,000	796,000	11,000	42,000	844,000	202,000	41,035,000	-18,629,000	2,151,000	4,191,000	3,064,000	3,261,000	6,267,000	3,727,000	4,290,000	11,996,000	3,262,000	6,215,000	3,697,000
operating expenses
research and development	21,495,000	30,531,000	48,968,000	47,275,000	45,709,000	50,639,000	41,231,000	35,806,000	37,368,000	35,275,000	31,955,000	27,415,000	22,857,000	16,546,000	15,413,000	12,219,000	12,430,000	13,701,000	13,766,000	15,143,000	19,816,000	15,180,000	12,663,000	12,256,000	14,555,000	11,412,000	10,627,000	10,106,000	8,845,000	7,555,000	8,171,000	7,436,000
sales, general and administrative
total operating expenses	31,182,000	51,639,000	67,155,000	65,603,000	60,514,000	65,212,000	56,034,000	48,588,000	48,042,000	45,399,000	40,838,000	34,623,000	28,771,000	22,427,000	20,584,000	17,155,000	16,642,000	18,137,000	17,958,000	19,586,000	23,968,000	19,560,000	16,894,000	15,827,000	17,611,000	14,317,000	12,831,000	12,402,000	10,785,000	9,153,000	9,997,000	9,057,000
operating income	-20,928,000	-41,656,000	-54,307,000	-55,180,000	-46,108,000	-59,852,000	-51,459,000	-46,534,000	-48,002,000	-45,388,000	-40,827,000	-34,612,000	-28,760,000	-22,416,000	-19,788,000	-17,144,000	-16,599,000	-17,293,000	-17,756,000	21,449,000	-22,781,000	-17,409,000	-12,703,000	-12,763,000	-14,350,000	-8,050,000	-9,104,000	-8,112,000	1,211,000	-5,891,000	-3,782,000	-5,360,000
net income	-19,544,000	-41,656,000	-54,307,000	-57,146,000	-45,888,000	-60,691,000	-52,979,000	-47,982,000	-48,983,000	-45,471,000	-40,913,000	-34,693,000	-28,842,000	-22,489,000	-19,786,000	-16,926,000	-16,246,000	-16,792,000	-17,071,000	21,901,000	-22,431,000	-17,069,000	-12,354,000	-12,403,000	-13,967,000	-7,732,000	-8,946,000	-8,061,000	1,259,000	-5,837,000	-3,766,000	-5,356,000

We provide you with 20 years income statements for Mersana Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Mersana Therapeutics stock. Explore the full financial landscape of Mersana Therapeutics stock with our expertly curated income statements.

The information provided in this report about Mersana Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.